Utechpus
  • Home
  • News
  • US
  • World
  • Politics
  • Business
  • Technology
  • Opinion
  • Health
  • Sports
  • Media
Saturday, February 27, 2021
No Result
View All Result
  • Home
  • News
  • US
  • World
  • Politics
  • Business
  • Technology
  • Opinion
  • Health
  • Sports
  • Media
No Result
View All Result
Utechpus
No Result
View All Result
Home Lifestyle Health

Vaccines Adapted for Variants Will Not Need Lengthy Testing, F.D.A. Says

admin by admin
February 22, 2021
in Health, Lifestyle
0
Vaccines Adapted for Variants Will Not Need Lengthy Testing, F.D.A. Says
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter


The Food and Drug Administration said on Monday that vaccine developers would not need to conduct lengthy randomized controlled trials for vaccines that have been adapted to protect against concerning coronavirus variants.

The recommendations, which call for small trials more like those required for annual flu vaccines, would greatly accelerate the review process at a time when scientists are increasingly anxious about how the variants might slow or reverse progress made against the virus.

The guidance was part of a slate of new documents the agency released on Monday, including others addressing how antibody treatments and diagnostic tests might need to be retooled to respond to the virus variants.

Together, they amounted to the federal government’s most detailed acknowledgment of the threat the variants pose to existing vaccines, treatments and tests for the coronavirus, and came weeks after the F.D.A.’s acting commissioner, Dr. Janet Woodcock, said the agency was developing a plan.

“The emergence of the virus variants raises new concerns about the performance of these products,” Dr. Woodcock said in a statement Monday. “We want the American public to know that we are using every tool in our toolbox to fight this pandemic, including pivoting as the virus adapts.”

Most of the vaccine manufacturers with authorized vaccines or candidates in late-stage trials have already announced plans to adjust their products to address the vaccine variants. The Moderna and Pfizer-BioNTech vaccines use mRNA technology that the companies have said can be used to alter the existing vaccines within six weeks, although testing and manufacturing would take longer.

Moderna has already begun developing a new version of its vaccine that could be used as a booster shot against a virus variant that originated in South Africa, known as B.1.351, which seems to dampen the effectiveness of the existing vaccines.

A fast-spreading coronavirus variant first observed in Britain has also gained a worrisome mutation that could make it harder to control with vaccines. That variant with the mutation was found in the United States last week.

Still, the guidance did not appear to be written with the assumption that new vaccines were imminent, or would be needed at all. Despite the recent indications that some variants — and particularly B.1.351 — make the currently authorized vaccines less effective, the shots still offer protection and appear to greatly reduce the severity of the disease, preventing hospitalizations and death.

Asked at a news briefing on Monday afternoon how much the variants would need to spread before updated vaccines were necessary, Dr. Woodcock did not give any specific criteria. “We need to anticipate this and work on it so that we have something in our back pocket before the threshold is upon us,” she said.

Updated 

Feb. 22, 2021, 5:39 p.m. ET

An updated Covid-19 vaccine can skip the monthslong process of a randomized clinical trial that would compare it with a placebo, the agency said. But a tweaked vaccine will still need to go undergo some testing. In trials proposed by the F.D.A., researchers will draw blood from a relatively small group of volunteers who have been given the adapted vaccine. Scientists will then observe what percentage of volunteers’ samples produce an immune response to the variants in the lab, and how large that response is. The vaccines will be judged acceptable if they produce an immune response that is relatively close to the one prompted by the original vaccines.

Dr. Peter Marks, the top vaccine regulator at the F.D.A., said at the news briefing that studies would include a “few hundred” people and last several months.

Volunteers will also be monitored carefully for side effects. The agency said the testing could be done in a single age group and then extrapolated to other age groups.

The guidance also encouraged the use of animal studies to support the case for modified vaccines, in case immune response studies come up with ambiguous conclusions.

The F.D.A. acknowledged that many questions remained unanswered, such as what type of data would trigger the need for an adapted vaccine and who would make that decision. The agency also noted that scientists had not yet determined the minimum level of antibodies in a vaccinated person’s blood that would protect someone from the virus.

Some other vaccines are regularly updated in a similar way. Because the influenza virus evolves rapidly from one year to the next, vaccine developers have to come up with new recipes annually.

The newly tweaked Covid-19 vaccines would be authorized under an amendment to the emergency authorization granted to the original vaccine, regulators said.



Source link

Previous Post

Century 21 is plotting a comeback in the US and NYC

Next Post

Immigrant lived in a church to dodge deportation, may stay

Next Post
Immigrant lived in a church to dodge deportation, may stay

Immigrant lived in a church to dodge deportation, may stay

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Max Homa overcomes near-debacle — and his Tiger Woods fear

Max Homa overcomes near-debacle — and his Tiger Woods fear

February 22, 2021
Top House budget Republican slams Biden’s $1.9T relief

Top House budget Republican slams Biden’s $1.9T relief

February 22, 2021
Read the document

Read the document

February 21, 2021
Billionaire LVMH boss Bernard Arnault takes Birkenstock stake

Billionaire LVMH boss Bernard Arnault takes Birkenstock stake

February 26, 2021
How to Walk Safely in the Snow, Ice and Slush

How to Walk Safely in the Snow, Ice and Slush

February 22, 2021
Anthony Davis-less Lakers pounded by NBA-best Jazz

Anthony Davis-less Lakers pounded by NBA-best Jazz

February 25, 2021
Twitter shares hit record high as it forecasts doubling revenue

Twitter shares hit record high as it forecasts doubling revenue

February 25, 2021

Griddy banned from Texas power marker over payment breach

February 27, 2021

Fanne Foxe, Who Plunged Into the Tidal Basin and Emerged Famous, Dies at 84

February 24, 2021

‘The Muppets’ slapped with a content warning by Disney

February 21, 2021

Uniform mix-up can’t stop Thunder from beating Hawks

February 27, 2021

Kevin Knox may play as Knicks mull how to fill Mitchell Robinson vacuum

February 21, 2021

Bill Maher sounds off ahead of Trumps CPAC speech

February 27, 2021

Hasbro reassures fans that Mr. Potato Head isn’t going anywhere

February 26, 2021

Car located in mysterious case of missing Colorado grandmother

February 26, 2021

Pennsylvania girl fatally stabbed wheelchair-bound sister: report

February 23, 2021
Utechpus

We bring you the best Premium WordPress Themes that perfect for news, magazine, personal blog, etc. Check our landing page for details.

Categories

  • Apps
  • Bussiness
  • Entertainment
  • Fashion
  • Food
  • Gadget
  • Gaming
  • Health
  • Lifestyle
  • Mobile
  • Movie
  • Music
  • News
  • Politics
  • Science
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent News

How One State Managed to Actually Write Rules on Facial Recognition

How One State Managed to Actually Write Rules on Facial Recognition

February 27, 2021
Bill Maher sounds off ahead of Trumps CPAC speech

Bill Maher sounds off ahead of Trumps CPAC speech

February 27, 2021

© 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • Home
  • Entertainment
    • Gaming
    • Movie
    • Music
    • Sports
  • Lifestyle
    • Fashion
    • Food
    • Travel
    • Health
  • News
    • Bussiness
    • Politics
    • Science
    • World
  • Tech
    • Apps
    • Gadget
    • Mobile

© 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.